Q3 2025 · 13F-HR
Eversept Partners, LPholdings as filed
Filed 2025-11-14 · accession 0001697013-25-000010
$1.45B
Reported value
86
Positions
2025-09-30
Period end
The Brief · Eversept Partners, LP · Q3 2025
AI · grounded in 13F
Eversept Partners, LP established a new position in QQQ valued at $138.1M. The fund also initiated new stakes in UTHR for $112.9M and GSK for $91.5M. Other new additions include NTRA and VERA, with investments of $83.6M and $81.6M respectively. The fund ended the period with 85 positions and total AUM of $1.45B.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 46090E103 | QQQ | INVESCO QQQ TR | $138.1M | 9.52% | 230,000 | PUT | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $106.2M | 7.32% | 253,220 | Common | SOLE |
| 37733W204 | GSK | GSK PLC | $91.5M | 6.31% | 2,120,446 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $83.6M | 5.76% | 519,644 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $81.6M | 5.62% | 2,807,836 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $53.3M | 3.68% | 3,467,314 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $51.2M | 3.53% | 1,421,983 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $51.2M | 3.53% | 877,373 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $47.6M | 3.28% | 111,700 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $41.5M | 2.86% | 1,924,306 | Common | SOLE |
| 98888T107 | ZIMV | ZIMVIE INC | $39.4M | 2.71% | 2,079,380 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $36.2M | 2.50% | 426,499 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $35.2M | 2.43% | 538,661 | Common | SOLE |
| 714046109 | RVTY | REVVITY INC | $34.6M | 2.38% | 394,311 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $33.9M | 2.33% | 1,417,204 | Common | SOLE |
| 09073M104 | TECH | BIO-TECHNE CORP | $32.9M | 2.27% | 591,540 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $29.9M | 2.06% | 1,153,920 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $27.5M | 1.90% | 1,363,653 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $22.3M | 1.54% | 687,129 | Common | SOLE |
| 203668108 | CYH | COMMUNITY HEALTH SYS INC NEW | $22.3M | 1.54% | 6,950,051 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $21.7M | 1.49% | 62,820 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $19.7M | 1.36% | 99,273 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $17.3M | 1.19% | 12,599,002 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC FORMERLY | $14.5M | 1.00% | 44,980 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $14.1M | 0.97% | 45,604 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $14.0M | 0.97% | 105,087 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $13.9M | 0.96% | 488,592 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $13.2M | 0.91% | 302,911 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $12.1M | 0.83% | 217,708 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $11.7M | 0.81% | 123,674 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $11.5M | 0.80% | 924,442 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $11.1M | 0.76% | 486,021 | Common | SOLE |
| 56400P706 | MNKD | MANNKIND CORP | $11.0M | 0.76% | 2,042,727 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $10.4M | 0.72% | 1,373,625 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $9.8M | 0.68% | 976,511 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $9.6M | 0.66% | 55,025 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $9.4M | 0.65% | 16,720 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $9.1M | 0.62% | 1,475,109 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $8.1M | 0.56% | 502,234 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $8.0M | 0.55% | 224,550 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $7.9M | 0.55% | 146,642 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $7.9M | 0.54% | 1,429,377 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $7.3M | 0.50% | 51,765 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $6.9M | 0.48% | 350,812 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $6.9M | 0.47% | 693,527 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $6.8M | 0.47% | 16,200 | PUT | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $6.5M | 0.44% | 14,426 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $5.8M | 0.40% | 392,441 | Common | SOLE |
| 42226A107 | HQY | HEALTHEQUITY INC | $5.0M | 0.34% | 52,388 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $4.7M | 0.32% | 166,391 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $4.5M | 0.31% | 48,054 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $4.4M | 0.30% | 1,488,725 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $4.3M | 0.30% | 16,652 | Common | SOLE |
| 75383L102 | RAPP | RAPPORT THERAPEUTICS INC | $4.3M | 0.29% | 143,565 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $3.8M | 0.26% | 272,706 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $3.6M | 0.25% | 49,314 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $3.5M | 0.24% | 158,742 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $3.5M | 0.24% | 164,237 | Common | SOLE |
| 09075A108 | BVS | BIOVENTUS INC | $2.9M | 0.20% | 433,933 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $2.8M | 0.20% | 49,890 | Common | SOLE |
| 023111404 | AMRN | AMARIN CORP PLC | $2.7M | 0.19% | 167,276 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $2.5M | 0.17% | 479,056 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $2.4M | 0.17% | 925,233 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $2.3M | 0.16% | 263,628 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $2.3M | 0.16% | 1,730,635 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $2.3M | 0.16% | 2,047,265 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $2.3M | 0.16% | 500,000 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $2.1M | 0.15% | 243,184 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $2.1M | 0.14% | 111,466 | Common | SOLE |
| 869367102 | STRO | SUTRO BIOPHARMA INC | $2.0M | 0.14% | 2,291,313 | Common | SOLE |
| 34965K107 | FTRE | FORTREA HLDGS INC | $1.8M | 0.13% | 219,384 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $1.8M | 0.12% | 9,470 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $1.6M | 0.11% | 134,619 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $1.5M | 0.10% | 194,440 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $1.2M | 0.08% | 824,594 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $998,794 | 0.07% | 20,856 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $992,106 | 0.07% | 76,997 | Common | SOLE |
| 70805E109 | PNTG | PENNANT GROUP INC | $957,856 | 0.07% | 37,980 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $834,232 | 0.06% | 290,673 | Common | SOLE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC NE | $711,093 | 0.05% | 11,343 | Common | SOLE |
| 28238P109 | EHTH | EHEALTH INC | $553,068 | 0.04% | 128,322 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $474,681 | 0.03% | 658,000 | PUT | SOLE |
| 76129W105 | RVP | RETRACTABLE TECHNOLOGIES INC | $305,911 | 0.02% | 363,315 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $251,366 | 0.02% | 59,992 | Common | SOLE |
| 15678C102 | CBLL | CERIBELL INC | $196,410 | 0.01% | 17,094 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $126,500 | 0.01% | 10,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.